From: Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry
Variable | Beta* | standard error | hazard ratio* |
---|---|---|---|
Stage | Â | Â | Â |
Stage 0 | 1.32 (0.05/2.59) | 0.65 | 3.76 (1.05/13.38) |
Stage I | Â | Â | Â |
Stage II | Â | Â | Â |
Grade | Â | Â | Â |
Grade 1 | 1.25 (0.29/2.21) | 0.49 | 3.50 (1.34/9,12) |
Grade 2 | Â | Â | Â |
Grade 3 | Â | Â | Â |
Histological type | Â | Â | Â |
Simple | -0.72 (-1.97/0.53) | 0.64 | 0.48 (0.14/1.71) |
Complex/mixed | Â | Â | Â |
Molecular group | Â | Â | Â |
Luminal-like A | -0.31 (-1.43/0.81) | 0.57 | 0.73 (0.24/2.24) |
Luminal-like B | Â | Â | Â |
Basal-like | Â | Â | Â |